The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Gonorrhea

Gonorrhea

Gonorrhea: A sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae.
It typically affects the urethra, cervix, rectum, or throat, and can lead to serious complications if left untreated.
Symptoms may include painful urination, unusual discharge, and abdominal pain.
Timely diagnosis and appropriate treatment are crucial for managing this condition and preventing its spread.
PubCompare.ai's AI-powered platform can help streamline your gonorrhea research by identifying the most reproducible and accurate protocols from the literature, preprints, and patents, enabling you to make well-informed decisions and drive your studies forward effciently.

Most cited protocols related to «Gonorrhea»

To assess the accuracy of Rockhopper’s transcript abundance estimates and the specificity of Rockhopper’s novel transcript identifications, we simulated an RNA-Seq experiment in N. gonorrhoeae using the Flux Simulator (http://flux.sammeth.net), which models RNA-seq experiments in silico. First, using the Flux Simulator, we simulated an artificial expression profile based on the 2002 annotated genes in the N. gonorrhoeae genome (21 (link)). The Flux Simulator chooses gene expression levels at random based on a mixed power and exponential law. We used a mean of 25 for the exponential distribution used to model variations in transcription start sites for each gene, we used random hexamers as primers for first strand synthesis during reverse transcription, and we used uniform random fragmentation during the Flux Simulator’s fragmentation process. The Flux Simulator’s default values were used for PCR amplification during final library preparation. Finally, we used the Flux Simulator to simulate 31 million single-end reads of length 72 nt. Rockhopper aligned to the N.gonorrhoeae genome ∼15 million of the sequencing reads produced by the Flux Simulator. We used these aligned reads together with the simulated expression profiles for the annotated N.gonorrhoeae genes to assess Rockhopper’s accuracy in quantifying transcript abundances and to evaluate Rockhopper’s propensity for false positive identifications of novel transcripts.
Full text: Click here
Publication 2013
Anabolism DNA Library Gene Expression Genes Genome Gonorrhea Neisseria gonorrhoeae Oligonucleotide Primers Reverse Transcription RNA-Seq Transcription Initiation Site
The Demo Project enrolled participants from municipal STI clinics in San Francisco and Miami and a community health center in Washington, DC from October 2012 to January 2014. These clinics have access to large populations of at-risk MSM, with annual HIV seroconversion rates of 2.3%-4%.13 (link) Participants were eligible if they were male at birth and 18 years or older; fluent in English or Spanish; had a negative rapid HIV antibody test at screening and enrollment and a negative 4th generation antibody/antigen (Ag/Ab) test at screening; had creatinine clearance ≥60 ml/min and a urine dipstick with negative or trace protein; and reported any of the following in the last 12 months: condomless anal sex with ≥2 male or transgender female partners; ≥2 episodes of anal sex with ≥1 HIV-infected partner; or sex with a male/transgender female partner and having a diagnosis of syphilis or rectal gonorrhea or chlamydia. Individuals with serious active medical conditions, a history of pathologic fracture, hepatitis B surface antigen positivity, or taking nephrotoxic medications were excluded. Written informed consent was obtained at screening, and eligible individuals returned for enrollment and were dispensed one month of TDF/FTC. The sample size allowed us to estimate proportions within margins of sampling error of +/− 4.4%, and to detect adjusted odds ratios of 1.7-2.3, depending on predictor and outcome prevalence.
Participants returned for clinic visits at 4, 12, 24, 36, and 48 weeks for HIV/STI testing, clinical monitoring, and PrEP dispensing. Participants were encouraged to return 4 weeks after stopping PrEP for a final evaluation and HIV test. Brief, client-centered counseling was provided at all visits [eMethods1]. Retention procedures were limited, with up to 3 contact attempts after a missed visit. Participants received $25 for each scheduled visit. PrEP was discontinued in seroconverters, who received counseling, partner services, and linkage to HIV primary care. TDF/FTC PrEP (donated by Gilead Sciences) and HIV/STI testing and safety monitoring (supported by the clinic or study funds) were provided free to participants. Among the 3 study sites, only the DC site offered PrEP outside the Demo Project. The protocol was approved by local institutional review boards.
Publication 2016
Antibodies Antigens Anus Chlamydia Creatinine Diagnosis Ethics Committees, Research Gonorrhea Hepatitis B Surface Antigens Hispanic or Latino Male Genital Organs Males Pathological Fracture Pharmaceutical Preparations Population at Risk Primary Health Care Proteins Rectum Retention (Psychology) Safety Syphilis Testing, AIDS Transgendered Persons Urine Woman
At every scheduled visit, subjects received a comprehensive package of prevention services, including HIV testing, risk-reduction counseling, condoms, and diagnosis and treatment of symptomatic sexually transmitted infections, including gonorrhea and chlamydia urethritis, syphilis, and herpes simplex virus type 2 (HSV-2). In addition, at 24-week intervals, subjects were screened for asymptomatic urethritis, syphilis, antibodies to HSV-2, and genital warts and ulcers; treatment was provided when indicated. Sexual partners were offered treatment of sexually transmitted infections that were diagnosed in the subject. Subjects were linked to local prevention and treatment services when required to receive standard-of-care services. All subjects were instructed to protect themselves from HIV with conventional methods, since they were unaware of their study-group assignment. Subjects who reported a recent unprotected exposure to an HIV-infected partner were referred for postexposure prophylaxis (at sites where such therapy was available), and the administration of a study drug was temporarily suspended. Vaccination against hepatitis B virus (HBV) was offered to all susceptible subjects.
Publication 2010
Antibodies B virus, Hepatitis Chlamydia Condoms Condylomata Acuminata Gonorrhea Human Herpesvirus 2 Post-Exposure Prophylaxis Sexually Transmitted Diseases Sexual Partners Syphilis Therapeutics Ulcer Urethritis Vaccination
We obtained isolates of N. gonorrhoeae from the Centers for Disease Control and Prevention's Gonococcal Isolate Surveillance Project (GISP), with samples collected as described [6 ]. Minimum inhibitory concentrations (MICs) were determined by agar dilution susceptibility testing, with some measurements confirmed by the Etest. Antimicrobial susceptibility was interpreted according to Clinical and Laboratory Standards Institute for ciprofloxacin [7 ], and according to Centers for Disease and Control and Prevention's guidelines for cefixime, ceftriaxone, and azithromycin, for which Clinical and Laboratory Standards Institute resistance criteria have not been established [8 ]. See the Supplementary Methods for further details.
Full text: Click here
Publication 2016
Agar Azithromycin Cefixime Ceftriaxone Ciprofloxacin Clinical Laboratory Services Epsilometer Test Gonorrhea Microbicides Minimum Inhibitory Concentration Susceptibility, Disease Technique, Dilution

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
Anus Chlamydia CTSB protein, human Eligibility Determination Gonorrhea HIV-1 HIV Vaccine Insertion Mutation Males Medical Devices Methamphetamine Needles Pharmaceutical Preparations Post-Exposure Prophylaxis Rectum SERPINA3 protein, human Specimen Collection Substance Use Syphilis

Most recents protocols related to «Gonorrhea»

Example 2

Chlamydia is a common STI that is caused by the bacterium Chlamydia trachomatis. Transmission occurs during vaginal, anal, or oral sex, but the bacterium can also be passed from an infected mother to her baby during vaginal childbirth. It is estimated that about 1 million individuals in the United States are infected with this bacterium, making chlamydia one of the most common STIs worldwide. Like gonorrhea, chlamydial infection is asymptomatic for a majority of women. If symptoms are present, they include unusual vaginal bleeding or discharge, pain in the abdomen, painful sexual intercourse, fever, painful urination or the urge to urinate more frequently than usual. Of those who develop asymptomatic infection, approximately half may develop PID. Infants born to mothers with chlamydia may suffer from pneumonia and conjunctivitis, which may lead to blindness. They may also be subject to spontaneous abortion or premature birth.

Diagnosis of chlamydial infection is usually done by nucleic acid amplification techniques, such as PCR, using samples collected from cervical swabs or urine specimens (Gaydos et al., J. Clin. Microbio., 42:3041-3045; 2004). Treatment involves various antibiotic regimens.

In some embodiments, the disclosed device can be used to detect chlamydial infections from menstrual blood or cervicovaginal fluids.

Full text: Click here
Patent 2024
Abdominal Pain Antibiotics Anus Asymptomatic Infections Bacteria Blindness Blood Childbirth Chlamydia Chlamydia Infections Chlamydia trachomatis Coitus Conjunctivitis Diagnosis Dysuria Fever Gonorrhea Infant Medical Devices Menstruation Mothers Neck Nucleic Acid Amplification Techniques Pain Patient Discharge Pneumonia Premature Birth Sexually Transmitted Diseases Spontaneous Abortion Transmission, Communicable Disease Treatment Protocols Urine Vagina Woman
Enrichment analysis was performed using the DAVID webpage3 (Sherman et al., 2022 (link)). The lists of up-regulated and down-regulated genes were selected by analyzing the fold change reported in the RNA-seq data. The identifier used in the lists was “LOCUS_TAG.” The genomic background used for enrichment calculation and functional annotation was that of N. gonorrhoeae strain TUM19854 (NZ_AP023069.1). The analysis was performed using Functional Annotation Tool of DAVID, and the results were analyzed as Functional Annotation Chart. The results were considered significant when the p value was <0.05.
Full text: Click here
Publication 2023
Genes Genome Gonorrhea Lanugo RNA-Seq Strains
The adaptive resistance of N. gonorrhoeae T2 and T9 was investigated using a gradient approach, as previously described with some modifications (Jahn et al., 2017 (link)). Gonococci were inoculated in GC broth tubes containing increasing concentrations (50% or 100% gradient) of thiostrepton and ampicillin and incubated at 37°C with shaking for 24 h. The first tube showing growth below the MIC value was used to inoculate a new set of tubes containing 100% or 50% increasing concentrations of the same antibiotic. This procedure was repeated sequentially for 14 days for each strain, for each antibiotic, and for each gradient. At each passage, the MIC value of thiostrepton or ampicillin was determined.
Full text: Click here
Publication 2023
Acclimatization Ampicillin Antibiotics Gonorrhea Neisseria gonorrhoeae Strains Thiostrepton
In this study, we used two urogenital clinical isolates of N. gonorrhoeae from female patients, named, respectively, T9 (a serotype 9 strain), and T2 (a serotype 2 strain; Martin et al., 1986 (link)). These strains were grown, from frozen stocks (−80°C), on GC agar base (OXOID) supplemented with 1% (v/v) Polyvitox (OXOID) at 37°C in a 5% CO2 incubator. The liquid medium used for growth was GC broth whose composition (per liter) is as follows: 15 g proteose peptone, 0.5 g corn starch, 4 g K2HPO4, 1 g KH2PO4, 5 g NaCl, 1% (v/v) Polyvitox (OXOID).
Thiostrepton (MIC 0.9 μg/mL; MBC 3.75 μg/mL), ampicillin (MIC 0.6 μg/mL; MBC 1.25 μg/mL), gentamicin (MIC 3.75 μg/mL; MBC 7.5 μg/mL), nalidixic acid (MIC 1.875 μg/mL; MBC 3.35 μg/mL), rifampicin (MIC 0.23 μg/mL; MBC 0.9 μg/mL), tetracycline (MIC 0.05 μg/mL; MBC 0.8 μg/mL), and DL-serine hydroxamate (MIC 1 mg/mL; MBC 4 mg/mL; all provided by Sigma-Aldrich) were used at the required concentration (values in brackets) in GC broth. Liquid cultures in GC broth were incubated at 37°C on rotary shaker at 200 rpm.
Full text: Click here
Publication 2023
Agar Ampicillin Cornstarch Freezing Gentamicin Gonorrhea Nalidixic Acid Patients potassium phosphate, dibasic proteose-peptone Rifampin serine hydroxamate Sodium Chloride Strains System, Genitourinary Tetracycline Thiostrepton Woman
Implementation was evaluated as the fidelity to completing all key components
of our care protocol. Specifically, this was defined as (1) completion of an
assessment visit by an infectious disease provider after receiving a
positive orthopox test result and (2) assessment for other STIs including
HIV; herpes simplex virus (HSV); syphilis; and urine, rectal, and pharyngeal
chlamydia and gonorrhea. Assessment for other STIs was deemed important
because of the high prevalence of coinfections in published cohorts with
monkeypox.9 (link)
Publication 2023
CARE protocol Coinfection Communicable Diseases Gonorrhea Rectum Sexually Transmitted Diseases Simplexvirus Syphilis Urine

Top products related to «Gonorrhea»

Sourced in United States, Germany, United Kingdom, France
IsoVitaleX is a sterile, cell culture medium supplement manufactured by BD. It is designed to support the growth and maintenance of various cell lines in vitro. The product provides a source of essential nutrients, growth factors, and other components required for cell culture applications.
Sourced in France, Sweden, United States, Germany, United Kingdom, Denmark, Italy, Australia, Spain, Switzerland, Japan
Etest is a quantitative antimicrobial susceptibility testing (AST) method developed by bioMérieux. It provides minimum inhibitory concentration (MIC) values for specific antimicrobial agents. Etest utilizes a predefined antimicrobial gradient on a plastic strip to determine the MIC of a tested microorganism.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United Kingdom, United States, Germany, Italy, France
The Vitox is a laboratory instrument designed for the analysis of volatile organic compounds (VOCs) in various sample types. It utilizes a combination of gas chromatography and mass spectrometry to separate, identify, and quantify individual VOCs within a sample. The Vitox provides accurate and reliable data for applications such as environmental monitoring, food and flavor analysis, and industrial process control.
Sourced in United States, New Zealand
The Aptima Combo 2 is a nucleic acid amplification test (NAAT) used for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clinical specimens. It is designed to provide accurate and reliable results for the diagnosis of these sexually transmitted infections.
Premarin is a laboratory-produced medication used to treat symptoms of menopause, such as hot flashes and vaginal atrophy. It contains a mixture of estrogen hormones derived from the urine of pregnant mares.
Sourced in France, United Kingdom
The API NH is a laboratory product designed for the identification of Neisseria and Haemophilus species. It is a standardized microbiology test system that provides biochemical identification of these bacterial species.
Sourced in Germany, United States, United Kingdom
D-glucose is a monosaccharide, the most common type of simple sugar. It is the primary source of energy for many organisms and plays a crucial role in various metabolic processes.
Sourced in United States
Thiamine pyrophosphate is a cofactor for several enzymes involved in carbohydrate metabolism. It is a derivative of the vitamin thiamine (vitamin B1).
Sourced in United States, United Kingdom, Germany, Sao Tome and Principe, Canada
Vitamin B12 is a laboratory product that serves as a source of the essential nutrient cobalamin. It is a water-soluble vitamin that plays a crucial role in the body's metabolism and the formation of red blood cells.

More about "Gonorrhea"

Gonorrhea, also known as the 'clap' or 'the drip', is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae.
This common infection primarily affects the urethra, cervix, rectum, or throat, and can lead to serious complications if left untreated.
Symptoms may include painful urination, unusual discharge, and abdominal pain.
Timely diagnosis and appropriate treatment are crucial for managing this condition and preventing its spread.
Effective diagnosis and treatment of gonorrhea often involves the use of specialized laboratory techniques and medical products.
For example, IsoVitaleX and Vitox are growth supplements used to culture the Neisseria gonorrhoeae bacterium, while the Etest is a method for determining antibiotic susceptibility.
SAS version 9.4 is a statistical software package that can be used to analyze data related to gonorrhea epidemiology and treatment outcomes.
In addition to these laboratory tools, gonorrhea management may also involve the use of specific medications.
Aptima Combo 2 is a nucleic acid amplification test used to detect the presence of Neisseria gonorrhoeae and Chlamydia trachomatis, two common STIs.
Premarin, a hormone replacement therapy, may be prescribed to help manage complications associated with gonorrhea in some patients.
The API NH test kit is used to identify the specific strain of Neisseria gonorrhoeae, which can inform treatment decisions.
Other important factors in gonorrhea research and management include understanding the role of nutrients and vitamins.
D-glucose is a crucial energy source for the Neisseria gonorrhoeae bacterium, while thiamine pyrophosphate and vitamin B12 are important cofactors in various metabolic processes.
By utilizing the insights and resources available, researchers and healthcare providers can streamline their gonorrhea studies and improve patient outcomes.
PubCompare.ai's AI-powered platform can help identify the most reproducible and accurate protocols from the literature, preprints, and patents, enabling well-informed decisions and efficient research progress.